Top Recruiting Trials
20 actively recruiting studies
Effect of Mental Imagery in Patients With Persistent Post-concussion Symptoms
Reuth Rehabilitation Hospital
n=60
Reuth Rehabilitation Hospital
Tel Aviv
Intervention OTHER: Provocation Test for Symptoms Using Mental Imagery — • The mental imagery task will be guided by the examiner through continuous verbal instruction (the examiner will provid...
Eligibility Ages 18 Years – 74 Years
Objectively Diagnose and Monitor Treatment of Light Sensitivity
Randy Kardon
n=120
University of Iowa Health Care
Iowa City, Iowa
Intervention DEVICE: Pupillography — A hand-held pupillometer/electroretinogram device (RETeval, LKC) will be held in front of the subject's eye, but will no...
Eligibility Ages 18 Years – 80 Years
Design and Implementation of a Carer Aromatherapy Training (CAT) Program for Children With Global Developmental Delay in Hong Kong: A Mixed Qualitative Study Using the COM-B Framework
Hong Kong Metropolitan University
n=30
Hong Kong Metropolitan University
Hong Kong
Intervention OTHER: Carer Aromatherapy Training (CAT) program and home massage with massage oil with the mixture of Petitgrain Mandarin (Citrus reticulate) essential oil and fractionated coconut oil — Carer Aromatherapy Training (CAT) program Following participants' consent to participate, an 8-hour face-to-face trainin...
Eligibility Ages 18 Years
Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
Zhejiang University
n=5000
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang
Eligibility Ages 18 Years
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
State University of New York - Upstate Medical University
n=60
SUNY Upstate Medical University
Syracuse, New York
Intervention DEVICE: Repetitive Transcranial Magnetic Stimulation — rTMS will be used to regulate the motor cortex to reduce headaches and post-concussion symptoms.
Eligibility Ages 18 Years – 55 Years
Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
n=30
National Institutes of Health Clinical Center
Bethesda, Maryland
Eligibility Ages 2 Years – 40 Years, MALE only
Hypersensitivity to Adrenomedullin in Post-Traumatic Headache
Danish Headache Center
n=21
Rigshospitalet-Glostrup
Glostrup Municipality
Intervention DRUG: Adrenomedullin — The participants will receive continuous intravenous infusion of 20 mL of 19.9 pmol/kg/min adrenomedullin over 20 minute...
Eligibility Ages 18 Years – 65 Years
Improving Status Epilepticus Treatment Times
Nationwide Children's Hospital
n=450
Nationwide Children's Hospital
Columbus, Ohio
Intervention OTHER: Quality improvement bundle — (1) standardizing BZD default to intranasal or buccal midazolam; (2) targeting initial BZD treatment within 10 minutes o...
Eligibility Ages 30 Days – 18 Years
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
Ruijin Hospital
n=60
Ruijin Hospital
Shanghai
Intervention DEVICE: rTMS — (1) The patient undergoes pseudo stimulus intervention in the first week and real stimulus intervention afterwards, whic...
Eligibility Ages 15 Years – 50 Years
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Hospital Universitari Vall d'Hebron Research Institute
n=700
University of Miami, Miller School of Medicine
Miami, Florida
Intervention DRUG: CGRP antibody or gepant — Patients will start anti-CGRP or its receptor antibody or gepants
Eligibility Ages 18 Years
HVLAT, Electric DN, Exercise Vs. Mobilization, STM, Exercise, TENS for Tension Type Headaches
Alabama Physical Therapy & Acupuncture
n=110
Maller and Swoverland Orthopedic PT
Fort Wayne, Indiana
Intervention OTHER: Thrust Manipulation, Electric Dry Needling and Exercise — Thrust Manipulation, Electric Dry Needling
Eligibility Ages 18 Years – 65 Years
Magnesium and Riboflavin Treatment for Post-Concussion Headache
University of Virginia
n=108
University of Virginia Student Health and Wellness Center
Charlottesville, Virginia
Intervention DRUG: magnesium and riboflavin supplement — Five capsules considered one dose of the intervention (one 400 mg magnesium capsule and four 100 mg riboflavin capsules)
Eligibility Ages 18 Years – 40 Years
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
USFetus
n=12
University of Southern California / Huntington Memorial Hospital
Los Angeles, California
Intervention DEVICE: Fetoscopy — Patients will receive fetoscopic repair of myelomeningocele. Patients with an anterior placenta will undergo the laparot...
Eligibility Ages 18 Years, FEMALE only
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment
Daniel A Tonetti, MD
n=80
Cooper University Health Care
Camden, New Jersey
Intervention DRUG: Lidocaine (drug) — Intra-arterial lidocaine infusion into bilateral middle meningeal arteries
Eligibility Ages 18 Years
Improving Diagnostics and Care After First Seizure
Haukeland University Hospital
n=200
Haukeland University Hospital
Bergen
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Xenon Pharmaceuticals Inc.
n=360
Clinical Trials, Inc.
Little Rock, Arkansas
Intervention DRUG: XEN1101 — XEN1101 Capsules
Eligibility Ages 18 Years
Magnetic Seizure Therapy for Schizophrenia - Trial
Centre for Addiction and Mental Health
n=80
University of British Columbia Hospital
Vancouver, British Columbia
Intervention DEVICE: Magnetic Seizure Therapy (MST) — MST treatment will be administered using the MagPro MST with a Cool TwinCoil over the frontal cortex in the midline posi...
Eligibility Ages 18 Years
Neurosurgical Outcome Network
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
n=4500
1. ASST Papa Giovanni XXIII
Bergamo, BG
Eligibility Ages 18 Years
Relieving Chronic Pain: Psychosomatic Mechanisms and Psychological Interventions in Fibromyalgia and Chronic Headache
University of Roma La Sapienza
n=400
Sapienza University of Rome
Rome, RM
Intervention BEHAVIORAL: Dynamic interpersonal therapy (DIT) — Dynamic interpersonal therapy (DIT) is a dynamically oriented brief psychotherapeutic intervention based on attachment a...
Eligibility Ages 18 Years – 50 Years, FEMALE only
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
Icahn School of Medicine at Mount Sinai
n=50
The Seaver Autism Center for Research and Treatment
New York, New York
Eligibility Ages 2 Years